View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Rituximab 375 / Polatuzumab Vedotin 1.8 / Bendamustine 90, diffuse large B-non-Hodgkin Lymphoma, cycle 1
Protocol-ID: 1422 V1.1 (Mini), RITU375/POLVED1.8/BEND90, DLBCL, C1Indication(s)
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 22.06.2022